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Omega‑3 fatty acids attenuate
cardiovascular effects of short‑term exposure
to ambient air pollution
Hao Chen1*†, Siqi Zhang2†, Wan Shen1,3†, Claudia Salazar4, Alexandra Schneider2, Lauren H. Wyatt4,
Ana G. Rappold4, David Diaz‑Sanchez4, Robert B. Devlin4, James M. Samet4 and Haiyan Tong4*

Abstract
Background: Exposure to air pollution is associated with elevated cardiovascular risk. Evidence shows that omega-3
polyunsaturated fatty acids (omega-3 PUFA) may attenuate the adverse cardiovascular effects of exposure to fine
particulate matter (PM2.5). However, it is unclear whether habitual dietary intake of omega-3 PUFA protects against
the cardiovascular effects of short-term exposure to low-level ambient air pollution in healthy participants. In the
present study, sixty-two adults with low or high dietary omega-3 PUFA intake were enrolled. Blood lipids, markers of
vascular inflammation, coagulation and fibrinolysis, and heart rate variability (HRV) and repolarization were repeatedly
assessed in 5 sessions separated by at least 7 days. This study was carried out in the Research Triangle area of North
Carolina, USA between October 2016 and September 2019. Daily P
 M2.5 and maximum 8-h ozone ( O3) concentrations
were obtained from nearby air quality monitoring stations. Linear mixed-effects models were used to assess the asso‑
ciations between air pollutant concentrations and cardiovascular responses stratified by the omega-3 intake levels.
Results: The average concentrations of ambient PM2.5 and O
 3 were well below the U.S. National Ambient Air Quality
Standards during the study period. Significant associations between exposure to P
 M2.5 and changes in total choles‑
terol, von Willebrand factor (vWF), tissue plasminogen activator, D-dimer, and very-low frequency HRV were observed
in the low omega-3 group, but not in the high group. Similarly, O3-associated adverse changes in cardiovascular
biomarkers (total cholesterol, high-density lipoprotein, serum amyloid A, soluable intracellular adhesion molecule 1,
and vWF) were mainly observed in the low omega-3 group. Lag-time-dependent biphasic changes were observed for
some biomarkers.
Conclusions: This study demonstrates associations between short-term exposure to PM2.5 and O
 3, at concentrations
below regulatory standard, and subclinical cardiovascular responses, and that dietary omega-3 PUFA consumption
may provide protection against such cardiovascular effects in healthy adults.
Keywords: Omega-3 polyunsaturated fatty acids, Ambient air pollution, PM2.5, O3, Cardiovascular
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Background
Ambient air pollution is a major global environmental
health problem. Exposure to ambient air pollution [particulate matter (PM) and ozone (O3)] was estimated to
be responsible for 4.51 million deaths worldwide in 2019
[1]. Among the health impacts of air pollution, cardiovascular diseases (CVD) garner great concern as ischemic
heart disease and stroke are the top two leading causes of
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death worldwide [2]. Short-term and long-term exposure
to fine PM (PM2.5) is linked to an elevated risk for myocardial infarction, stroke, heart failure, and arrhythmia,
and potentiates development of chronic cardiometabolic
conditions such as diabetes [3].
As oxidative stress and inflammation are important
mechanistic pathways mediating air pollution-associated
cardiovascular effects, research has been undertaken to
investigate potential interventional strategies at an individual level, focusing on these pathways to confer cardiovascular protection. Some omega-3 polyunsaturated fatty
acids (PUFA) are dietary fats from marine sources [4].
Mechanistically, marine omega-3 PUFA, eicosapentaenoic acid (EPA, 20:5) and docosahexaenoic acid (DHA,
22:6), can serve as antioxidants and are also substrates
for the synthesis of specialized pro-resolving mediators (SPMs) that orchestrate key signaling processes in
mediating the resolution of inflammation and a return to
homeostasis [5, 6]. Evidence shows that dietary omega-3
PUFA intake in the dose range of 2–4 g/day as fish or
fish-oil products is associated with 25–40% lower blood
triglyceride and possibly reduced cardiovascular risk
among CVD patients [7].
A few studies have reported health benefits of
omega-3 PUFA against air pollution exposure. We previously showed that fish oil supplementation (3 g/day
for 4 weeks) attenuated adverse cardiac and lipid effects
associated with a 2-h exposure to concentrated ambient particulate matter (avg. 278 µg/m3) in healthy middle-aged participants in a controlled exposure study
setting [8]. Lin and colleagues reported that fish oil supplementation (2.5 g/day for 2 months) blunted ambient
PM2.5 (avg. 38 µg/m3)—induced changes in biomarkers
of inflammation, coagulation, and endothelial function
among young adults in China [9]. Fish oil supplementation also alleviated systemic oxidative stress caused by
ambient O3 and nitrogen dioxide in the same participants
[10]. It should be noted that the air pollutant levels in
these studies were higher than the U.S. National Ambient Air Quality Standards (NAAQS). However, evidence
has shown increased cardiovascular risk in populations
exposed to air pollution at concentrations below the
established air quality standards, especially in susceptible groups [11, 12]. Thus, knowledge gaps remain on
whether increased dietary omega-3 PUFA consumption
can attenuate cardiovascular effects caused by ambient
air pollution at low levels.
In this panel study, participants were enrolled based
on their habitual omega-3 PUFA dietary intake and
stratified according to their erythrocyte omega-3 index.
We focused on subclinical endpoints of blood lipids,
vascular inflammation, coagulation and fibrinolysis,
and heart rate variability (HRV) and repolarization.
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We hypothesized that habitual omega-3 PUFA consumption can alleviate adverse cardiovascular effects
induced by short-term exposure to low levels of ambient PM2.5 and O3.

Results
Descriptive statistics

Of the 62 enrolled participants, the majority (56) completed 5 sessions, while 3 completed 4 sessions and
another 3 completed 3 sessions. As shown in Table 1, 28
participants were in the low omega-3 group and 34 in
the high group. No statistical differences were observed
in age, sex, race, smoking history, BMI, or systolic and
diastolic blood pressure between the two groups. As
expected, the difference in omega-3 index between the
low and high groups was statistically significant (4.0% vs.
6.8%, p < 0.001). The description of all cardiovascular biomarkers across all sessions in both low and high omega-3
groups are presented in Additional file 1: Table S1.
During the study period, daily P
 M2.5 concentrations
ranged from 1.8 to 68.0 µg/m3, with a mean of 10.2 µg/
m3 and an IQR of 4.7 µg/m3. Average maximum 8-h O3
concentration was 40.8 ppb (range 10–71 ppb, IQR:
17 ppb). Temperature and relative humidity ranged
from -8.6 to 31.1 °C and 30 to 100%, respectively. We
observed weak or moderate correlations between air
pollutants and meteorological measurements (Table 2).
Table 1 Participant characteristics
Low
omega-3
(n = 28)
Age (years), mean (SD)

37 (8)

High
omega-3
(n = 34)
40 (9)

All (n = 62)

38 (9)

Sex, n (%)
Male

10 (35.7)

13 (38.2)

23 (37.1)

Female

18 (64.3)

21 (61.8)

39 (62.9)
14 (22.6)

Race, n (%)
African American

9 (32.1)

5 (14.7)

Asian

0 (0)

3 (8.8)

3 (4.8)

19 (67.9)

26 (76.5)

45 (72.6)

22 (78.6)

32 (94.1)

54 (87.1)

6 (21.4)

2 (5.9)

Caucasian
Smoking history, n (%)
Never-smoker
Ex-smoker
BMI (kg/m2), mean (SD)
Omega-3 index (%), mean (SD)

24.9 (3.3)
4.0 (0.8)

24.4 (3.1)
6.8 (1.2)*

8 (12.9)
24.6 (3.2)
5.5 (1.7)

SBP (mmHg), mean (SD)

113.0 (8.8)

109.9 (9.9)

111.3 (9.5)

DBP (mmHg), mean (SD)

71.5 (6.7)

69.5 (7.3)

70.4 (7.1)

Statistical difference between low and high omega-3 groups was derived using
Kruskal–Wallis rank sum tests for continuous variables and Fisher’s exact tests
for categorical variables, *p < 0.05 for the difference between groups. BMI, body
mass index; DBP, diastolic blood pressure; SBP, systolic blood pressure; SD,
standard deviation
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Table 2 Distribution and correlation of air pollution concentrations and meteorological measurements during the study period (Oct.
6, 2016–Sep. 5, 2019)
Mean (SD)

Range

IQR

Spearman correlation coefficient
PM2.5

PM2.5 (µg/m3)

10.2 (4.1)

1.8–68.0

O3_8h (ppb)

40.8 (11.1)

10–71

17

0.16

0.8–24.2

3.8

0.45

− 8.6 to 31.1

15.2

− 0.10

NO2 (ppb)

5.3 (3.8)

Temperature (°C)

16.5 (8.9)

Relative humidity (%)

70.2 (15.6)

O3

NO2

Temperature

4.7

30–100

22.2

− 0.19

− 0.13
0.47

− 0.46

− 0.42

− 0.21

0.17

IQR, interquartile range; NO2, nitrogen dioxide; O3, ozone; PM, particulate matter; SD, standard deviation

Overview of the regression results

As summarized in Table 3, differential effects of ambient air pollution on cardiovascular biomarkers were
observed in the low and high omega-3 groups. Specifically, in the low omega-3 group, significant associations
were observed between increased air pollutant concentrations and changes in cardiovascular biomarkers.
However, in the high omega-3 group, the associations
were either null or in a direction of mitigation of the
adverse effects. The detailed results are described
below. We only report effect estimates [95% confidence
interval (CI)] for markers significantly associated with
either PM2.5 or O
 3 and pinteraction if between-group difference was significant (pinteraction < 0.1).

Effects of blood omega‑3 PUFA on the association
between PM2.5 exposure and cardiovascular biomarkers

The significant effects of 
PM2.5 on total cholesterol,
vWF, tPA, D-dimer, and VLF were observed in the low
omega-3 group, but not in the high group (Table 3,
Fig. 1). Specifically, in the low omega-3 group: an IQR
increase in the concentration of PM2.5 was associated
with decreased total cholesterol at lag1 [-2.4% (-4.3%,
-0.4%)], lag2 [-2.2% (-4.0%, -0.4%)], and 5dMA [-3.7%
(-6.5%, -0.8%)] (Fig. 1A); PM2.5 was positively associated
with vWF at lag0 [6.3% (1.1%, 11.8%), pinteraction = 0.099]
while the association shifted to negative at lag3 [-5.8%
(-10.0%, -1.5%), pinteraction = 0.07] and lag4 [-4.9% (-9.2%,
-0.4%)] (Fig. 1B); PM2.5 was associated with increased
tPA at lag3 [6.1% (1.0%, 11.4%)] (Fig. 1C); PM2.5 was

Table 3 Summary of associations between air pollutant and cardiovascular biomarkers in low and high omega-3 groups
Outcome

PM2.5
Low omega-3

O3
High omega-3

Low omega-3

High omega-3

↑L0, ↓L2-4

↓L1

Blood lipids
Total cholesterol
HDL
LDL
Vascular inflammation
SAA
sICAM-1
sVCAM-1
Coagulation/fibrinolysis factors
tPA
vWF
D-dimer
HRV and repolarization
VLF
P complexity

↓L1−2 and 5dMA
→

→

→

↓L2−4 and 5dMA

→

→

→

→

↓L1

→

→

↑L1 and 5dMA

→

→

→

↑L0
→

→

↑L3

→

→

→

↑L1, ↓L4

→

→

→

→

→

→

↑L0, ↓L3−4

↓L0
→

→

→

→

↑L4 and 5dMA

↑L0

→

↓L4

→

→

Arrows “↓, ↑, and →” indicate negative, positive and null associations between air pollutant and cardiovascular biomarker, respectively. 5dMA, 5-day moving average;
HDL, high density lipoprotein; HRV, heart rate variability; L0, lag0; L1, lag1; L2, lag2; L3, lag3; L4, lag4; LDL, low density lipoprotein; O3, ozone; PM, particulate matter;
SAA, serum amyloid A; sICAM-1, soluble intercellular adhesion molecule 1; tPA, tissue plasminogen activator; VLF, very-low frequency; vWF, von Willebrand factor
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Fig. 1 Influence of omega-3 PUFA on PM2.5 affected cardiovascular biomarkers. Effect estimates (95% CI) in total cholesterol (A), vWF (B), tPA (C),
D-dimer (D), VLF (E), and P complexity (F) were corresponded to an IQR increase in PM2.5 concentrations in the low (blue) and high (red) omega-3
groups. * p < 0.05 for significant association within a group. # pinteraction < 0.1 and ## pinteraction < 0.05 for significant differences in the effect estimates
between groups

associated with increased D-dimer at lag1 [13.1%, (1.0%,
26.8%), pinteraction = 0.09] but the association was negative
at lag4 [-11.1% (-20.6%, -0.6%)] (Fig. 1D); PM2.5 was also
associated with decreased VLF at lag0 [-20.2% (-34.8%,
-2.2%)] (Fig. 1E). These associations were not observed in
the high omega-3 group. In the high omega-3 group, positive associations between PM2.5 and P complexity were
observed at lag4 [7.7% (2.1%, 13.6%), pinteraction = 0.03]
and 5dMA [12.0% (2.5%, 22.5%)] (Fig. 1F). No significant
effects of PM2.5 on other biomarkers were observed in
either group (Additional file 1: Tables S2-S6).
Effects of blood omega‑3 PUFA on the association
between O3 exposure and cardiovascular biomarkers

Similar to the findings with P
 M2.5 exposure, significant
associations between O
 3 exposure and the biomarkers were observed in the low omega-3 group with only
a few found in the high group (Table 3, Fig. 2). In the
low omega-3 group: an IQR increase in the concentration of 
O3 was significantly associated with increases
in total cholesterol at lag0 [3.8% (0.9%, 6.9%), pinteraction = 0.02] but the association was negative at lag2
[-3.5% (-6.2%, -0.8%)], lag3 [-2.9% (-5.6%, -0.2%)], and
lag4 [-2.9% (-5.2%, -0.4%)] (Fig. 2A); O3 exposure was
significantly associated with decreases in HDL at lag2
[-5.0% (-8.8%, -1.0%), pinteraction = 0.03], lag3 [-4.5% (-8.3%,

-0.6%), pinteraction = 0.01], lag4 [-3.6% (-7.1%, -0.1%), pinteraction = 0.05], and 5dMA [-9.2% (-15.4%, -2.4%), pinteraction = 0.01] (Fig. 2C); O3 exposure was significantly
associated with increases in SAA at lag1 [27.2% (3.1%,
57.0%)] and 5dMA [47.5% (2.3%, 112.7%)] (Fig. 2D); O3
exposure was also associated with increases in sICAM-1
[4.4% (1.0%, 7.9%), pinteraction = 0.03] and vWF [14.0%
(6.9%, 21.5%), pinteraction < 0.01)] at lag0 (Figs. 2E and 2F).
In the high omega-3 group, a negative association was
observed between O
 3 and total cholesterol [-2.7% (-5.1%,
0.1%), pinteraction = 0.07] and between O3 and LDL [-5.3%
(-8.8%, -1.8%), pinteraction = 0.01] at lag1 (Figs. 2A and 2B).
We did not observe significant associations between O
 3
exposure and other cardiovascular biomarkers in either
group (Additional file 1: Table S2-S6).
All effect estimates remained stable in two pollutant
models (Additional file 1: Table S7–S8) and after excluding outliers (Additional file 1: Table S9), indicating that
the air pollutants act independently and that the effect
estimates are not likely to be driven by outcome outliers.

Discussion
In the present study, we investigated the potential cardioprotective effects of dietary omega-3 PUFA consumption against short-term exposure to low levels of
ambient air pollution in healthy adults. As summarized
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Fig. 2 Influence of omega-3 PUFA on O3 affected cardiovascular biomarkers. Effect estimates (95% CI) in total cholesterol (A), LDL (B), HDL (C), SAA
(D), sICAM-1 (E), and vWF (F) were corresponded to an IQR increase in O3 concentrations in the low (blue) and high (red) omega-3 groups. *p < 0.05
for significant association within a group. #pinteraction < 0.1 and ##pinteraction < 0.05 for significant differences in the effect estimates between groups

in Fig. 3, we examined a range of cardiovascular biomarkers in response to exposure to ambient P
 M2.5 and O3, and
report protective effects of higher omega-3 PUFA levels
in mitigating changes in blood lipids, vascular inflammation, coagulation and fibrinolysis, and HRV.
Although the average concentrations of ambient air
pollution during this study period were well below the
U.S. NAAQS (24-h PM2.5: 35 μg/m3; 8-h O
 3: 70 ppb),
significant changes in cardiovascular biomarkers were
observed in association with these short-term exposures. Similarly, several studies have reported short-term
exposure to ambient P
 M2.5 below the NAAQS levels was
associated with cardiovascular effects in susceptible individuals in the U.S. [13–15]. In addition, some studies
showed that long-term exposure to P
 M2.5, PM10, or N
 O2
at concentrations below established air quality standards
was significantly associated with increased cardiovascular and respiratory risk among susceptible populations
[11, 12]. These findings highlight the need for research
on the low-level air pollution-induced health effects and
potential interventions that may be effective against such
low-level exposures.
Previous efforts have been made to identify interventional approaches to reduce the adverse health effects of
air pollution [16]. Mechanistically, air pollution inducedcardiovascular effects are partly driven by oxidative stress
and inflammation, suggesting an approach using dietary

supplementation with antioxidant and anti-inflammatory
agents [17]. Marine omega-3 PUFA are rich in oxidizable carbon–carbon double bonds and are substrates for
the synthesis of SPMs. These features of omega-3 PUFA
confer antioxidant and anti-inflammatory properties and
therefore may blunt the pathophysiology of arteriosclerosis and acute coronary syndrome [4]. A meta-analysis
of 13 clinical trials reported a consensus that omega-3
PUFA supplementation lowers the risk for myocardial
infarction, coronary heart disease and CVD [18]. Two
controlled randomized trials have demonstrated that
dietary fish oil supplementation provided cardioprotective effects against high levels of PM2.5 exposure [8,
9]. Our results are in line with these studies in that we
show omega-3 PUFA can mitigate adverse cardiovascular
effects caused by exposure to air pollution.
Elevated blood lipids, especially triglycerides, total
cholesterol and LDL are risks factors for CVD, while
increased HDL is considered protective [19]. In the
present study, decreased total cholesterol levels were
observed in association with PM2.5 in the low omega-3
group. This result is in line with another study conducted
in North Carolina showing that short-term exposure
to ambient PM2.5 was associated with decreased blood
lipid levels in diabetic patients [13]. However, it should
be noted that both LDL and HDL, two important lipoproteins for cardiovascular risks, were not affected by
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Fig. 3 Schematic showing cardiovascular benefits of dietary omega-3 PUFA against short-term exposure to ambient air pollution. Healthy
participants were enrolled in the low and high omega-3 groups based on their dietary omega-3 PUFA intake. Associations between exposure to
ambient PM2.5 and O3 and cardiovascular biomarkers in blood and heart rate variability were assessed. Differential impacts of dietary omega-3 PUFA
were observed on the cardiovascular biomarkers in response to short-term exposure to low-level ambient air pollution. DHA, docosahexaenoic
acid; EPA, eicosapentaenoic acid; HDL, high-density lipoprotein; LDL, low-density lipoprotein; PM2.5, fine particulate matter; SAA, serum amyloid A;
sICAM-1, soluble intercellular adhesion molecule 1; tPA, tissue plasminogen activator; VLF, very-low frequency; vWF, von Willebrand factor
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 M2.5 regardless of omega-3 PUFA levels. Our previous
P
controlled exposure study also reported that fish oil supplementation did not change the blood HDL and LDL
associated with PM2.5 exposure [8], suggesting that dietary supplementary omega-3 PUFA did not significantly
alter these lipoproteins. Triglyceride levels in the high
omega-3 group showed a decreasing trend (Additional
file 1: Table S1) that was not seen in the low omega-3
group, consistent with the use of fish oil supplementation
for the treatment of hypertriglyceridemia [20].
Coagulation and fibrinolysis are two highly regulated
and inter-related processes in response to tissue injury,
ensuring balanced homeostasis of thrombus formation
and degradation. vWF plays a major role in blood coagulation by binding to factor VIII and promoting platelet
adhesion to injured vasculature [21]. tPA is a serine protease that converts plasminogen to plasmin for fibrin
degradation, while D-dimer is a product of the fibrin degradation process [21, 22]. In the present study, elevated
vWF was associated with immediate P
M2.5 exposure
(lag0), but the association shifted to null or negative at
delayed lag days in the low omega-3 group, suggesting an
acute PM2.5 impact on the increased coagulation activity. Consistently, a meta-analysis showed that a positive
association between short-term P
 M2.5 exposure and vWF
was only observed within 3 days of the exposure [23]. An
association between P
 M2.5 exposure and elevated tPA
or D-dimer in the low omega-3 group suggests an active
fibrinolytic process in response to P
 M2.5 exposure. Interestingly, none of the significant findings mentioned above
were found in the high omega-3 group, suggesting participants with high blood omega-3 PUFA levels were less
susceptible to PM2.5 induced coagulation and fibrinolytic
activities. Lin and colleagues also reported amelioration
of plasma vWF and plasminogen by fish oil supplements
in response to PM2.5 exposure in young subjects [9].
HRV is an index of autonomic nervous system control on the heart. A meta-analysis of 29 epidemiological studies showing that exposure to P
 M2.5 could alter
HRV, including LF and HF [24]. Changes in VLF power,
strongly correlated with normal sinus beats, have been
shown to be associated with the risk for arrhythmic death
[25]. In this study, a negative association between P
 M2.5
and VLF was observed in the low omega-3 group at lag0,
implying possible effects on normal sinus beats associated with acute P
 M2.5 exposure. P
 M2.5-induced increases
in P-wave complexity were observed at lag4 and 5dMA
only in the high omega-3 group. As increased P-wave
indices are associated with abnormal atrial conduction
[26], our results suggest that omega-3 PUFA may affect
atrial conduction with short-term exposure to 
PM2.5,
although this finding warrants further investigation. Most
of these changes were prominent in the low but not in the
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high omega-3 group, suggesting that omega-3 PUFA may
modulate PM2.5-induced cardiac changes. However, caution is advised when interpreting the HRV results given
that these healthy participants were exposed to low levels
of ambient air pollution and the transient HRV changes
may not be captured by a relatively short period of monitoring in this study.
Similarly, most adverse associations between O3 and
cardiovascular biomarkers were in the low omega-3
group while the associations were either null or protective in the high omega-3 group. Specifically, most
significant associations between blood lipids or vascular inflammation biomarkers and O3 exposure were
observed in the low omega-3 group. The significant
changes in total cholesterol and HDL in the low omega-3
group and LDL in the high omega-3 group, suggesting
that dietary omega-3 PUFA may maintain a blood lipid
profile in favor of reduced cardiac risk in response to O
 3
exposure. As O3 is considered a strong oxidant that can
promote blood lipid oxidation [27], the quenching or
antioxidant properties of omega-3 PUFA may mitigate
such effects.
SAA is a biomarker of acute inflammation and tissue
injury while sICAM-1 and sVCAM-1 participate in leukocyte adhesion to the endothelium and play an important role in all stages of atherosclerosis [28]. Increased
SAA, sICAM-1 and sVCAM-1 levels in association with
O3 were found in the low omega-3 group, but not in the
high group, indicating the protection of omega-3 PUFA
against O3-induced vascular inflammation. Data on the
modifying effects of omega-3 PUFA on ozone-induced
health effects are sparse. A study showed amelioration of
fish oil on systemic oxidative stress induced by ambient
O3 and N
 O2 exposure in human subjects [10]. An animal
study also found vasoprotective effects and alleviation of
cardiac dysfunction of fish oil supplementation against
O3 exposure (800 ppb) in rats [29, 30].
It is noteworthy that we observed a lag-time-dependent biphasic change in several biomarkers in the low
omega-3 group. Specifically, the positive associations
between PM2.5 or O3 and total cholesterol, LDL, sICAM1, vWF, and D-dimer were mainly observed at lag0 or
lag1, but the associations trended null and negative at
lag2-4. These observations indicate that the air pollutantinduced adverse effects are acute and normally reversible,
which are consistent with current literature [31, 32]. The
null and negative associations at delayed lag days suggest that the low-level of air pollution in our study did
not have an extended adverse impact on the assessed
biomarkers. This could be partly explained by the active
defensive responses to limit and resolve the adverse
effects in the subclinical biomarkers caused by low-level
of air pollution. Omega-3 PUFA is an antioxidant that
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can readily react with oxidant air pollutants potentially
mitigating their interaction with tissue targets. On the
other hand, prolonged exposure to air pollution may
generate reactive oxidized lipid products that are biologically active. We recently reported that a high omega-3
index protected lung function decrements associated
with ozone exposure in the immediate term but potentiated the effect on lagging days [33]. Nevertheless, these
changes were mainly observed in the low omega-3 group,
implying that an increased susceptibility to adverse
impacts of air pollution are in participants who are deficient in omega-3 PUFA.
We stratified participants into low and high groups
based on their blood omega-3 index with the cutoff values of < 4% and > 5.5% respectively. Omega-3 indices
approximately 4% and 5.5% correlate with relatively high
and low risk for coronary heart disease, respectively [34].
Although there is no consensus in clinical practice on
optimal omega-3 index values for cardiovascular health,
there have been studies supporting the notion that a
higher omega-3 index is cardioprotective [34, 35]. The
American Heart Association recommends that patients
with coronary heart diseases consume 1 g per day of EPA
and DHA to lower the CVD risk. The recently approved
highly purified prescription form of EPA (Icosapent
ethyl) has been shown to significantly reduce cardiovascular risk in patients with hypertriglyceridemia [20], further promoting the use of omega-3 PUFA in CVD. We
also reported beneficial modification of dietary omega-3
PUFA on the association between short-term exposure
to ambient NO2 and respiratory and cardiovascular outcomes [36]. Taken together, these findings suggest that
dietary omega-3 PUFA may confer cardioprotective benefits against adverse health effects of exposure to ambient
air pollution in healthy adults even at levels below current air quality standards.
The findings of this study are noteworthy in several
respects. First, this observational study was carried
out with participants conducting their daily activities,
making the findings more generalizable to real-life scenarios. Second, the 24-h dietary recall methodology
employed to monitor dietary intake of EPA + DHA for
each participant throughout the study indicated that the
EPA + DHA intake levels remained relatively stable for
both low and high omega-3 groups [37]. Third, this is the
first study to report cardiovascular benefits of omega-3
PUFA against exposure to lower-than-NAAQS levels
of PM2.5 and O
 3, indicating its potential as an interventional strategy against health effects of low-level air pollution. Fourth, relatively high omega-3 PUFA levels were
achieved by participants through habitual fish and/or fish
oil consumption, suggesting long-term cardiovascular

Page 8 of 11

benefits of dietary omega-3 PUFA against exposure to air
pollution.
There are also a few limitations of this study. This study
did not recruit participants who are considered susceptible to air pollution, such as the elderly and those with
pre-existing cardiovascular diseases. Nonetheless, we
have observed moderating effects of omega-3 PUFA on
changes of cardiovascular biomarker associated with
ambient air pollutants, and it is likely that these effects
would be more prominent if susceptible population were
included. This study employed a relatively small sample
size and short-term exposure scenario; thus, caution is
warranted inferring causal association and long-term
implication of the findings. Only the health effects of
PM2.5 and O3 were considered in the study while there
might be other components of air pollution in play such
as secondary organic aerosols. Furthermore, air pollution
data were based on central air quality monitoring stations
rather than individual exposure metrics such as location,
time spent indoor vs. outdoor, and activity level, which
could possibly introduce non-differential exposure misclassification. Finally, even though we have restricted dietary and medication usage during the study period, other
factors such as lifestyle (exercise, balanced diet, stress,
etc.) could be potential confounders.

Conclusions
This observational study demonstrates that habitual dietary omega-3 PUFA may provide benefits in ameliorating the cardiovascular effects associated with short-term
exposure to low levels of ambient air pollutants including PM2.5 and O3. These findings suggest that dietary
omega-3 PUFA intake may offer a simple and effective
interventional approach at an individual level to mitigate
the adverse cardiovascular effects of exposure to ambient
air pollution.
Methods
Study population and design

The study was carried out in Central North Carolina
from October 2016 to September 2019. Healthy participants meeting the following criteria were recruited:
25–55 years old; body mass index (BMI) between 19 and
35; having no history of cardiovascular disease, chronic
respiratory disease, cancer, uncontrolled hypertension
(≥ 140 systolic, ≥ 90 diastolic), or diabetes; non-smokers for at least 1 year; not taking β-adrenergic receptor
blockers, anti-inflammatory drugs, and statins. Participants were recruited from Research Triangle area in close
proximity to the U.S. Environmental Protection Agency
(U.S.EPA) Human Studies Facility (HSF) in North Carolina, USA.
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Eligible participants were further screened and
enrolled into low or high omega-3 PUFA groups meeting
one of the following criteria: 1) As described previously
[38], an inhouse open-ended dietary questionnaire was
used to screen participants whose EPA + DHA intake
was less than 0.5 g/week (low) or at least 3 g/week (high)
for 6 months or longer; 2) Omega-3 index (OmegaQuant,
Sioux Falls, SD), a measurement of EPA and DHA in
erythrocyte membrane, was employed to screen participants whose omega-3 index was less than 4.0% (low) or at
least 5.5% (high).
Each enrolled volunteer visited the Human Studies
Facility (HSF) of the U.S.EPA for up to 5 sessions separated by at least 7 days between two sessions. Participants were instructed to keep their diet routine during
the study and refrain from using any pain medications
for two weeks before each session. Each session consists of two visits on consecutive days. On the first day,
participants were outfitted with a Holter monitor and
recorded continuously for 30 min. On the second day,
venous blood was collected for biomarker measurements
and Holter monitoring was recorded for 30 min. Written
informed consent was given by all participants prior to
enrollment. The study was approved by the Institutional
Review Board of the University of North Carolina at
Chapel Hill and the U.S.EPA and registered at ClinicalTrials.gov (NCT02921048).
Exposure assessment

Hourly concentrations of ambient P
 M2.5 and O
 3 were
obtained from a central air quality monitoring station
(Millbrook) approximately 44 km (27 miles) from the
HSF. Twenty four-hour average concentrations of PM2.5
were calculated from hourly pollutant data averaged
between 9 and 8 AM, with a valid day defined as having
at least 18 hourly measurements over the 24-h period.
Daily maximum 8-h O3 concentrations were defined as
the highest 8-h moving average concentrations between 9
and 8 AM. For missing data, an alternative central monitoring station (Durham Armory) approximately 18 km
(11 miles) from the HSF was employed. Concentrations
were assigned to each visit session (the day of blood
sample collection is defined as lag0), as well as to 4 days
prior (lag1–lag4), and the 5-day moving average (5dMA).
Twenty four-hour averages of N
 O2 concentration, air
temperature and relative humidity were collected from
the same monitoring station.
Venous blood samples

A portion of each blood sample was sent to a commercial
lab (LabCorp, Burlington, NC) for quantification of blood
lipids. The remainders of the blood samples were separated for plasma and stored at -80 ℃ prior to biomarker
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analysis. Commercially available multi-array plates were
used to quantify levels of von Willebrand factor (vWF),
tissue plasminogen activator (tPA), and D-dimer (MesoScale, Rockville, MD). In addition, vascular inflammation biomarkers including soluable intercellular adhesion
molecule 1 (sICAM-1), soluable vascular cell adhesion
molecule 1 (sVCAM-1), and serum amyloid A (SAA)
were measured using a multiplex kit from MesoScale
Diagnostics (Gaithersburg, MD). All experiments were
performed per manufacturers’ instructions.
Holter monitoring

As described previously [39], a Holter monitor was
placed on the participants on both days of each session.
The participants reclined in a dark room for 30 min
and Holter were recorded using a H12 + 12-Lead ECG
Recorder (Mortara, Milwaukee, WI). HRV and repolarization parameters were measured during the last
5 min of Holter recording. Time-domain measurements
[standard deviation of normal-to-normal (SDNN), rootmean square of successive differences (rMSSD)] and
frequency-domain measurements [very-low frequency
(VLF), normalized low frequency (LFn), normalized high
frequency (HFn), and low-to-high frequency power (LF/
HF)] were measured. Cardiac repolarization was assessed
by measuring the QT interval and corrected by heart rate
(QTc). T wave complexity was measured in each beat by
principal component analysis based on all 12 leads and
averaged. QRS complexity and P wave complexity was
calculated with the Mortara software.
Statistical analysis

The data analysis was performed using R (version 3.6.2)
with the “gamm4” package. To improve normality in the
residuals, we log-transformed all dependent variables
except for LFn and HFn. Generalized linear mixed models with random subject effects were employed to analyze
the associations between exposure to air pollutants and
cardiovascular biomarkers. Based on the repeated measurements in the same subjects, this approach assessed
the within-subject variabilities in biomarkers under different exposure levels. The statistical model was adjusted
for age, sex, race, BMI, long-term and seasonal trends,
day of the week, temperature, and relative humidity. The
long-term and seasonal trends were controlled for by a
penalized spline of time with eight degrees of freedom
(df ) per year. Temperature (lag0-1 for high temperatures
and lag 0–4 for low temperatures) and relative humidity
(lag0-4) were incorporated as penalized splines with the
df selected by the Generalized Cross Validation criterion.
Linear terms of P
 M2.5 and O
 3 were included in the model
separately to assess the immediate (lag0), delayed (lag1
to lag4), or cumulative (5-day moving average, 5dMA)
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effects. A product term of omega-3 groups and air pollutant concentrations was added to assess between-group
differences. The results were interpreted as percent
change from the mean of the measured outcome per
interquartile range (IQR) increase of exposure. We also
conducted two sensitivity analyses to test the robustness
of the results. First, we restricted analyses to outcome
data without outliers (defined as those lower than 1st
quartile − 3 × IQR and those higher than 3rd quartile + 3
× IQR). Second, we adjusted the analyses using a 2-pollutant model; for example, we adjusted effect estimates
of biomarkers per IQR increase in PM2.5 with either O3
or NO2 concentrations at the same lag. Statistical significance was set at a two-sided p < 0.05 for the air pollution
effects and a two-sided p < 0.1 for the interaction with the
two groups.
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